SEC Form 4 · accession 0001445866-17-000793
InfuSystem Holdings, Inc · INFU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
BlueLine Partners, L.L.C.
Director · 10% Owner
BlueLine Capital Partners II, L.P.
Director · 10% Owner
Meridian OHC Partners, LP
Director · 10% Owner
Meridian TSV II, LP
Director · 10% Owner
TSV Investment Partners, LLC
Director · 10% Owner
Period of report
May 24, 2017
Accepted (ET)
May 26, 2017 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337013
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 24, 2017 | P | 1,105 | $1.55 | A | 2,661,410 | D | |
| Common StockF1 | May 25, 2017 | P | 5,000 | $1.55 | A | 2,666,410 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.